New Delhi, April 16 (IANS) With India aiming to eliminate tuberculosis (TB) by 2025, five years ahead of the global target, whole-genome sequencing (WGS) may play a significant role in identifying cases of drug-resistant TB early and improving outcomes, reveals a study on Tuesday.
Tuberculosis stands as the second leading infectious disease killer globally, with over 2.95 million active cases reported in 2020 alone in India. Of these, 135,000 were classified as multidrug-resistant TB cases.
The study by HaystackAnalytics, an IIT-Bombay startup, in collaboration with Dr. D.Y. Patil Medical College, Pune, is based on data from 600 patients with drug-resistant TB in India.
Data gathered using the WGS method revealed that pre-extensively drug-resistant TB (pre-XDR-TB) was present in 50.83 per cent of cases, while multidrug-resistant TB (MDR-TB) was found in 15.5 per cent, with nearly equivalent proportions among men and women.
These patients were not only resistant to rifampicin — a drug used to manage and treat diverse mycobacterial infections –, and isoniazid — an antibiotic indicated in the first-line treatment of active Mycobacterium tuberculosis (TB) infection –, but also to fluoroquinolones — which is used widely as therapy for respiratory and urinary tract infections, the researchers said.
“I believe, going forward, whole-genome sequencing might become the first among many tests, which will be prescribed to all TB patients, not only in India, everywhere else in the world,” Dr. Anirvan Chatterjee, CEO and Co-founder at HaystackAnalytics, told IANS.
“WGS is the new gold standard for TB diagnosis and is the way forward for the world for eliminating TB cases,” he added.
Further, the study showed that 55 per cent of people between 15-35 years of age and 67 per cent up to 14 years of age had pre-XDR TB.
“Indeed younger people are getting tuberculosis, which is a cause of concern because this is a productive age group and TB is highly detrimental to the young population,” Anirvan said.
“In fact, there is a lot of drug resistance in the younger age group, which is of very high concern, for reasons of productivity,” he said, noting that it also increases the risk of active transmission of drug-resistant TB.
He explained that “WGS can find drug resistance to 18 antibiotics in a single test,” eliminating the need for multiple tests
“If this is available or is sought for when the earliest signs of tuberculosis occur, then the therapy will be shorter. It will also improve the outcome. If the right antibiotic is given to a person, transmission reduces by more than 90 per cent, which means that we will be able to reduce new TB cases. And that is the holy grail,” the doctor told IANS.
–IANS
rvt/svn
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
